The board of directors of China Health Group Inc. provided earnings guidance for the year ended 31 December 2015. For the period, the group is expected to record a loss as compared with the profit recorded by the group for the financial year ended 31 December 2014. Changing the profit to the expected net loss is mainly attributable to the fair value loss on derivative financial liabilities arising from the preliminary assessment on the valuation of the unlisted convertible notes issued on 24 December 2014, and the gain on waiver of convertible note of RMB 52,897,000 included the principal and interest accrued because in the year of 2014, the company paid off the notes of an aggregate principal amount of CHF 15,000,000, which was issued on 10 September 2007.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.112 HKD | 0.00% | 0.00% | -18.84% |
26/03 | China Health Group Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
12/03 | China Health Group Inc. Announces Directorate Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-18.84% | 14.26M | |
+48.64% | 56.65B | |
-6.44% | 39.44B | |
+38.73% | 39.03B | |
+14.28% | 26.75B | |
-11.17% | 26.86B | |
-21.40% | 19.03B | |
+25.64% | 12.26B | |
+0.96% | 12.28B | |
+27.04% | 12.04B |
- Stock Market
- Equities
- 8225 Stock
- News China Health Group Inc.
- China Health Group Inc. Provides Earnings Guidance for the Year Ended 31 December 2015